October 20, 2008 – TomoTherapy Inc. said it has signed a letter of intent with Hitachi Medical Corp. (HMC) to distribute the im treatment system in Japan.
Terms of the agreement between TomoTherapy and HMC are being finalized. The partnership between TomoTherapy and Hitachi Medical Corporation is expected to commence by the end of 2008.
For more information: www.tomotherapy.com
July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...
July 09, 2024 
March 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...
March 14, 2022
October 22, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...
October 22, 2021
October 27, 2020 — A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical ...
October 27, 2020
June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...
June 10, 2020
